| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 48 | 2025 | 1350 | 8.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 47 | 2025 | 960 | 7.800 |
Why?
|
| Genomic Structural Variation | 25 | 2025 | 94 | 7.600 |
Why?
|
| Sequence Analysis, DNA | 51 | 2025 | 1833 | 6.770 |
Why?
|
| Genomics | 41 | 2025 | 1675 | 6.420 |
Why?
|
| Software | 23 | 2025 | 737 | 5.280 |
Why?
|
| Computational Biology | 13 | 2025 | 887 | 2.860 |
Why?
|
| Genetic Variation | 19 | 2025 | 1621 | 2.460 |
Why?
|
| Haplotypes | 14 | 2024 | 562 | 2.270 |
Why?
|
| DNA Methylation | 9 | 2025 | 1143 | 2.170 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2024 | 2940 | 1.850 |
Why?
|
| DNA Copy Number Variations | 14 | 2025 | 1022 | 1.680 |
Why?
|
| Benchmarking | 11 | 2025 | 147 | 1.500 |
Why?
|
| Genome | 12 | 2024 | 526 | 1.350 |
Why?
|
| Sequence Alignment | 4 | 2025 | 630 | 1.350 |
Why?
|
| Alleles | 8 | 2025 | 1705 | 1.230 |
Why?
|
| Genotyping Techniques | 5 | 2025 | 110 | 1.210 |
Why?
|
| Algorithms | 7 | 2025 | 1736 | 1.200 |
Why?
|
| Tandem Repeat Sequences | 3 | 2024 | 38 | 1.160 |
Why?
|
| Nanopores | 8 | 2022 | 11 | 1.080 |
Why?
|
| Mosaicism | 3 | 2025 | 248 | 1.000 |
Why?
|
| Polymorphism, Genetic | 2 | 2023 | 896 | 0.950 |
Why?
|
| Humans | 101 | 2025 | 133935 | 0.920 |
Why?
|
| Chromosome Mapping | 7 | 2023 | 1123 | 0.920 |
Why?
|
| Hominidae | 1 | 2024 | 27 | 0.910 |
Why?
|
| Metagenomics | 2 | 2024 | 110 | 0.880 |
Why?
|
| Population Health | 1 | 2024 | 43 | 0.830 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 138 | 0.820 |
Why?
|
| Transcriptome | 6 | 2025 | 1127 | 0.790 |
Why?
|
| Germ Cells | 3 | 2025 | 203 | 0.790 |
Why?
|
| Genotype | 9 | 2025 | 2807 | 0.760 |
Why?
|
| Hybridization, Genetic | 3 | 2019 | 23 | 0.750 |
Why?
|
| Cryptosporidium | 1 | 2022 | 34 | 0.750 |
Why?
|
| INDEL Mutation | 7 | 2024 | 94 | 0.750 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 28 | 0.750 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 44 | 0.750 |
Why?
|
| Whole Genome Sequencing | 11 | 2025 | 327 | 0.740 |
Why?
|
| Industrial Development | 1 | 2021 | 3 | 0.730 |
Why?
|
| DNA Transposable Elements | 3 | 2021 | 188 | 0.690 |
Why?
|
| Perciformes | 2 | 2017 | 9 | 0.670 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 773 | 0.640 |
Why?
|
| Neoplasms | 6 | 2025 | 3027 | 0.630 |
Why?
|
| Microbiota | 1 | 2024 | 443 | 0.600 |
Why?
|
| Arabidopsis | 4 | 2019 | 94 | 0.530 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 838 | 0.530 |
Why?
|
| Molecular Sequence Annotation | 4 | 2025 | 162 | 0.530 |
Why?
|
| Genome, Viral | 4 | 2025 | 187 | 0.470 |
Why?
|
| Genome, Plant | 6 | 2020 | 30 | 0.460 |
Why?
|
| Base Sequence | 9 | 2023 | 3170 | 0.460 |
Why?
|
| Chromosomes, Human, Y | 2 | 2025 | 50 | 0.440 |
Why?
|
| Genetics, Population | 4 | 2024 | 198 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 1871 | 0.400 |
Why?
|
| Germ-Line Mutation | 3 | 2025 | 368 | 0.390 |
Why?
|
| Animals | 23 | 2025 | 36387 | 0.390 |
Why?
|
| Glucosylceramidase | 3 | 2022 | 27 | 0.380 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1910 | 0.370 |
Why?
|
| Gene Frequency | 3 | 2022 | 778 | 0.370 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2087 | 0.370 |
Why?
|
| Machine Learning | 2 | 2024 | 331 | 0.350 |
Why?
|
| Diploidy | 3 | 2020 | 39 | 0.350 |
Why?
|
| Mutation | 7 | 2025 | 6297 | 0.350 |
Why?
|
| Parkinson Disease | 3 | 2023 | 734 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 3475 | 0.340 |
Why?
|
| DNA, Circular | 2 | 2020 | 19 | 0.340 |
Why?
|
| Chromatin | 2 | 2025 | 609 | 0.320 |
Why?
|
| Phenotype | 9 | 2025 | 4548 | 0.310 |
Why?
|
| Exome | 3 | 2023 | 1067 | 0.300 |
Why?
|
| Chromosome Inversion | 3 | 2024 | 75 | 0.300 |
Why?
|
| Chromosomes, Human | 4 | 2022 | 137 | 0.300 |
Why?
|
| Schizosaccharomyces | 2 | 2019 | 66 | 0.290 |
Why?
|
| Brain | 4 | 2024 | 3221 | 0.280 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 319 | 0.280 |
Why?
|
| Gene Duplication | 4 | 2024 | 371 | 0.270 |
Why?
|
| Circadian Clocks | 2 | 2019 | 71 | 0.270 |
Why?
|
| Genome, Fungal | 2 | 2017 | 34 | 0.270 |
Why?
|
| Evolution, Molecular | 4 | 2019 | 709 | 0.270 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 529 | 0.260 |
Why?
|
| Gene Rearrangement | 4 | 2024 | 332 | 0.260 |
Why?
|
| Genetic Testing | 3 | 2023 | 1094 | 0.250 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3751 | 0.250 |
Why?
|
| Human Genome Project | 2 | 2024 | 56 | 0.250 |
Why?
|
| Epigenomics | 2 | 2025 | 195 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1409 | 0.240 |
Why?
|
| Lymphoma | 2 | 2021 | 335 | 0.240 |
Why?
|
| Cell Line | 4 | 2024 | 2836 | 0.230 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 103 | 0.230 |
Why?
|
| Sequence Analysis | 2 | 2023 | 54 | 0.230 |
Why?
|
| Pitheciidae | 1 | 2024 | 1 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 2 | 2023 | 57 | 0.220 |
Why?
|
| Organ Specificity | 1 | 2025 | 444 | 0.220 |
Why?
|
| Chromosomes, Human, X | 1 | 2025 | 161 | 0.220 |
Why?
|
| DNA | 4 | 2022 | 1674 | 0.210 |
Why?
|
| RNA Editing | 2 | 2014 | 36 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 165 | 0.210 |
Why?
|
| Adenosine Deaminase | 2 | 2014 | 89 | 0.210 |
Why?
|
| Metagenome | 1 | 2024 | 158 | 0.200 |
Why?
|
| Blood Cells | 1 | 2022 | 55 | 0.200 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 2763 | 0.200 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2025 | 224 | 0.200 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2020 | 68 | 0.200 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 21 | 0.190 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 44 | 0.190 |
Why?
|
| Mesocricetus | 1 | 2022 | 74 | 0.190 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2024 | 312 | 0.190 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 71 | 0.190 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 542 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 358 | 0.190 |
Why?
|
| Phylogeny | 5 | 2025 | 784 | 0.180 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2025 | 366 | 0.180 |
Why?
|
| Macaca mulatta | 1 | 2023 | 514 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 348 | 0.180 |
Why?
|
| Bias | 1 | 2021 | 147 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 347 | 0.180 |
Why?
|
| Reproductive Isolation | 2 | 2019 | 4 | 0.180 |
Why?
|
| Genomic Instability | 1 | 2022 | 244 | 0.180 |
Why?
|
| Songbirds | 1 | 2020 | 8 | 0.170 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 20 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 216 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2021 | 244 | 0.160 |
Why?
|
| Polychondritis, Relapsing | 1 | 2019 | 5 | 0.160 |
Why?
|
| Forensic Genetics | 1 | 2020 | 11 | 0.160 |
Why?
|
| Microcephaly | 1 | 2023 | 347 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 2122 | 0.160 |
Why?
|
| Workflow | 1 | 2020 | 133 | 0.160 |
Why?
|
| Genome, Mitochondrial | 1 | 2019 | 34 | 0.160 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 283 | 0.160 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 237 | 0.160 |
Why?
|
| Domestication | 1 | 2019 | 5 | 0.160 |
Why?
|
| Annelida | 1 | 2019 | 1 | 0.160 |
Why?
|
| Gaucher Disease | 1 | 2019 | 12 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 732 | 0.150 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 977 | 0.150 |
Why?
|
| Sexual Maturation | 1 | 2019 | 49 | 0.150 |
Why?
|
| Fishes | 1 | 2019 | 41 | 0.150 |
Why?
|
| Deafness | 1 | 2019 | 85 | 0.150 |
Why?
|
| Arthritis | 1 | 2019 | 86 | 0.150 |
Why?
|
| Precision Medicine | 1 | 2022 | 355 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 398 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 501 | 0.140 |
Why?
|
| Gene Amplification | 1 | 2018 | 247 | 0.140 |
Why?
|
| Oncogenes | 1 | 2018 | 179 | 0.140 |
Why?
|
| Introduced Species | 1 | 2017 | 27 | 0.140 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 609 | 0.140 |
Why?
|
| Tidal Waves | 1 | 2016 | 1 | 0.130 |
Why?
|
| Chironomidae | 1 | 2016 | 2 | 0.130 |
Why?
|
| Heterozygote | 4 | 2022 | 718 | 0.130 |
Why?
|
| Acclimatization | 1 | 2016 | 24 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 374 | 0.130 |
Why?
|
| Proteome | 1 | 2019 | 281 | 0.130 |
Why?
|
| Bass | 1 | 2016 | 2 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 111 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2019 | 701 | 0.130 |
Why?
|
| Exons | 1 | 2019 | 832 | 0.130 |
Why?
|
| Ananas | 1 | 2015 | 1 | 0.130 |
Why?
|
| Genome, Insect | 1 | 2016 | 116 | 0.120 |
Why?
|
| Critical Care | 1 | 2022 | 693 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2014 | 951 | 0.120 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 3056 | 0.120 |
Why?
|
| Photosynthesis | 1 | 2015 | 13 | 0.120 |
Why?
|
| Biological Evolution | 1 | 2017 | 256 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 453 | 0.120 |
Why?
|
| Leukemia Virus, Feline | 1 | 2015 | 5 | 0.120 |
Why?
|
| Retroviridae Infections | 1 | 2015 | 10 | 0.120 |
Why?
|
| Cat Diseases | 1 | 2015 | 16 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1076 | 0.120 |
Why?
|
| Candida albicans | 1 | 2015 | 90 | 0.120 |
Why?
|
| Reference Standards | 3 | 2023 | 245 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 124 | 0.120 |
Why?
|
| Proteomics | 1 | 2019 | 592 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 885 | 0.110 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 317 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 136 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 295 | 0.110 |
Why?
|
| Male | 14 | 2025 | 65904 | 0.110 |
Why?
|
| Candidiasis | 1 | 2015 | 138 | 0.110 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 141 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2019 | 930 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2015 | 631 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 291 | 0.110 |
Why?
|
| Female | 15 | 2025 | 71684 | 0.110 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2012 | 9 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 397 | 0.100 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2024 | 73 | 0.100 |
Why?
|
| Sulfites | 1 | 2012 | 31 | 0.100 |
Why?
|
| Nucleotides | 2 | 2022 | 94 | 0.100 |
Why?
|
| CpG Islands | 2 | 2025 | 347 | 0.090 |
Why?
|
| Clonal Evolution | 2 | 2023 | 49 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2012 | 354 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2024 | 577 | 0.090 |
Why?
|
| Telomere | 2 | 2023 | 230 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 870 | 0.080 |
Why?
|
| Plant Breeding | 2 | 2020 | 15 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 464 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2021 | 253 | 0.080 |
Why?
|
| Databases, Genetic | 2 | 2024 | 501 | 0.080 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 232 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 1418 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2025 | 14802 | 0.070 |
Why?
|
| Pedigree | 2 | 2023 | 1694 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 1045 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2021 | 562 | 0.060 |
Why?
|
| Reproduction | 2 | 2019 | 245 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 98 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 40 | 0.060 |
Why?
|
| Neanderthals | 1 | 2025 | 1 | 0.060 |
Why?
|
| Adolescent | 4 | 2025 | 20536 | 0.060 |
Why?
|
| Clone Cells | 1 | 2025 | 180 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2024 | 54 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 75 | 0.060 |
Why?
|
| China | 1 | 2025 | 295 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 141 | 0.050 |
Why?
|
| DNA, Satellite | 1 | 2023 | 16 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 2161 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2023 | 49 | 0.050 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2023 | 81 | 0.050 |
Why?
|
| Virus Integration | 1 | 2023 | 40 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 25 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 231 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 92 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 20 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 43 | 0.050 |
Why?
|
| Multigene Family | 1 | 2023 | 323 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 365 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 77 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 483 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2022 | 94 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 189 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2021 | 22 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 199 | 0.050 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 26 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 125 | 0.050 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 109 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2022 | 334 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 258 | 0.040 |
Why?
|
| New York City | 1 | 2021 | 63 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2023 | 206 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2021 | 220 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 240 | 0.040 |
Why?
|
| Ecotype | 1 | 2020 | 4 | 0.040 |
Why?
|
| Inbreeding | 1 | 2020 | 9 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 472 | 0.040 |
Why?
|
| Reference Values | 1 | 2022 | 742 | 0.040 |
Why?
|
| Retroelements | 1 | 2020 | 41 | 0.040 |
Why?
|
| Haploidy | 1 | 2020 | 20 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 346 | 0.040 |
Why?
|
| Child | 3 | 2025 | 25742 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 600 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 212 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 313 | 0.040 |
Why?
|
| Mice | 4 | 2025 | 18909 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2021 | 261 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2022 | 154 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 82 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 150 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 211 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 138 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 365 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 498 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 176 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 317 | 0.040 |
Why?
|
| Flowers | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2020 | 142 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 226 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 412 | 0.040 |
Why?
|
| Plants, Genetically Modified | 1 | 2019 | 45 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 82 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8591 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1484 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 55 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 237 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 267 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2020 | 225 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 148 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2020 | 366 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 242 | 0.040 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 105 | 0.040 |
Why?
|
| Aging | 1 | 2025 | 1302 | 0.040 |
Why?
|
| Genome Size | 1 | 2017 | 18 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 289 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 372 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 452 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 809 | 0.030 |
Why?
|
| Chromosomes, Fungal | 1 | 2017 | 49 | 0.030 |
Why?
|
| Moon | 1 | 2016 | 13 | 0.030 |
Why?
|
| DNA, Plant | 1 | 2016 | 12 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 363 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 31 | 0.030 |
Why?
|
| Basidiomycota | 1 | 2016 | 13 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2017 | 58 | 0.030 |
Why?
|
| Vitis | 1 | 2016 | 16 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 315 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 212 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2016 | 78 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1217 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 292 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 570 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 789 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 174 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 630 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 317 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 825 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 248 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 126 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 3981 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 279 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5183 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2017 | 362 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 559 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 75 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 402 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 791 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 375 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 371 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3167 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2163 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1195 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 844 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1814 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 21745 | 0.020 |
Why?
|
| Cytosine | 1 | 2012 | 59 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2022 | 2704 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1326 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 813 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1629 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1757 | 0.020 |
Why?
|
| Middle Aged | 2 | 2022 | 29409 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 837 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 259 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 222 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 537 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1370 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7522 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3639 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6590 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13163 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4899 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4822 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2902 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31950 | 0.010 |
Why?
|